麻豆果冻传媒影音

Gamification of daily step goals and financial incentives resulted in over 1 year. (Circulation)

varies widely between healthy middle-aged individuals and cannot be predicted by typical clinical variables. (Heart)

In the DEDICATE-DZHK6 population, designed to be more reflective of routine clinical practice, matched surgery for outcomes at 1 year among people at low or intermediate surgical risk. (New England Journal of Medicine)

are under class I recall due to reports of increased resistance in the guidewire handle and chamber during use, the FDA announced.

Around 10% of all deaths following percutaneous coronary intervention , according to research highlighted by the University of Michigan.

Coronary artery bypass grafting surgery may be feasibly planned . (European Heart Journal)

Investigational APOC3-targeting small interfering RNA (siRNA) therapy reduced serum triglycerides in patients with severe hypertriglyceridemia in a phase IIb study. (JAMA Cardiology)

Early data support as a siRNA for reducing lipoprotein(a) concentrations in people with stable heart disease. (JAMA)

Esperion pointed to the consistent clinical benefits of bempedoic acid (Nexletol) in the CLEAR Outcomes trial.

With mechanical thrombectomy in stroke patients identified on CT perfusion imaging, recanalization was still linked to better functional outcomes, a retrospective study showed. (Stroke)

People with diabetic cardiomyopathy did not show improved exercise capacity after taking the AT-001. (Journal of the American College of Cardiology)

Smartphone motion sensors allowed CardioSignal algorithms to in a multicenter prospective study. (JACC: Heart Failure)

For rural Native Americans with limited access to care, a for heart failure with reduced ejection fraction boosted uptake of guideline-directed medical therapy. (JAMA Internal Medicine)

Older people with heart failure who displayed , the shortness of breath after bending over, had disproportionately higher mortality rates. (European Journal of Preventive Cardiology)

The existing bone drug etidronate slowed the progression of , a rare disease. (Vascular Medicine)

Like other racial groups, show a link between social determinants of health and cardiovascular disease risk factors. (Journal of the American Heart Association)

Comment